GeneGene: RBP4

Retinol-binding protein 4 (RBP4)

RBP4 is the serum carrier that delivers vitamin A (retinol) from the liver to peripheral tissues, including the eye. Lowering circulating RBP4 reduces the retinal delivery of vitamin A and the formation of the toxic byproducts implicated in Stargardt disease and dry AMD.

1
Drugs
1
Trials tracked
1
Resolved
1
Indications

Drugs hitting this target

Trials targeting RBP4

1 benchmark

Indications

About RBP4

What is RBP4?

RBP4 is the serum carrier that delivers vitamin A (retinol) from the liver to peripheral tissues, including the eye. Lowering circulating RBP4 reduces the retinal delivery of vitamin A and the formation of the toxic byproducts implicated in Stargardt disease and dry AMD.

Which drugs target RBP4?

Therapies acting on RBP4 tracked here include Tinlarebant.

References